Eli Lilly has made a six-year, $50 million commitment to UNICEF USA to support efforts to improve the prevention, detection and management of noncommunicable diseases. More: Eli Lilly delivers M boost to UNICEF’s pediatric health push Source: fierce
read moreFollowing an FDA approval in muscle-invasive bladder cancer patients who are eligible to receive cisplatin-based chemotherapy, AstraZeneca on Thursday reported positive phase 3 results for its Imfinzi, used alongside Padcev, in those who were cisplatin-ineligible. More: AstraZeneca scores with Imfinzi
read moreWith the FDA now rudderless following the revelation that commissioner Marty Makary, M.D., is stepping down, voices across biopharma have joined in support of the FDA’s former top drug regulator Richard Pazdur, M.D., as President Donald Trump’s next logical pick
read moreThe framework would leverage existing safety data on approved drugs to provide new options to patients with unmet medical needs, the FDA explained. More: FDA floats possible approach to repurpose approved drugs under new uses Source: fierce
read moreGenerics juggernaut Sun Pharma is pulling one lot of a chemotherapy drug in the United States as the issue of particulate contamination crops up once again on the FDA’s recall register. More: Sun recalls US chemotherapy batch, citing glass particle
read more© 1994 - 2026 B.M. Pharmaceuticals